Top

25-04-2024 | Anthracycline | Research

Evaluation the Effect of Anthracyclines on Cardiac Function in Children Lymphoma Survivors by Left Ventricular Myocardial Work

Authors: Yuqiong An, Li Xue, Liyuan Xu, Chao Zhang, Yijie Yang, Yong Liu, Ning Ma

Abstract

Anthracycline chemotherapy is associated with the left ventricular (LV) dysfunction, but the conventional echocardiographic parameter is insensitive in detecting subclinical cardiac dysfunction, and the role of echocardiography in children cancer survivors (CCSs) has not been well established. Here, the myocardial work (MW) was employed to evaluate the early effect of the anthracyclines on LV function in children lymphoma survivors, as well as to explore the clinical application value of this modality. 51 children lymphoma survivors treated with anthracyclines were included. During the treatments, the echocardiography was performed at baseline (T0 phase), the 3rd (T1 phase) and 6th (T2 phase) chemotherapeutic cycle, respectively. After that, the conventional echocardiographic parameters, LV global longitudinal strain (GLS), and global myocardial work (GMW) parameters were obtained. Finally, these echocardiographic parameters were compared to distinguish the differences among three groups, and correlation analysis was used to identify relationship between GMW parameters and LV GLS. Compared with the baseline, we found that there are no significant differences for LVEF and other conventional echocardiographic parameters after chemotherapy, but the value of LV lateral E/E’ increased at T1 and T2 group. The GLS, global work index, global constructed work, and global work efficiency were decreased, while the global wasted work was increased after chemotherapy (all P < 0.05). The correlation analysis showed that the GLS has significant correlation with GMW parameters (all P < 0.001). The MW, as a new noninvasive echocardiography modality, could be used to quantitatively evaluate the LV MW in children lymphoma survivors treated with anthracyclines, which providing a sensitive method to early detect the children’s LV dysfunction after the chemotherapy.

Available only for authorised users

Giusca S, Korosoglou G, Montenbruck M, Gersak B, Schwarz AK, Esch S, Kelle S, Wulfing P, Dent S, Lenihan D, Steen H (2021) Multiparametric early detection and prediction of cardiotoxicity using myocardial strain, T1 and T2 mapping, and biochemical markers: a longitudinal cardiac resonance imaging study during 2 years of follow-up. Circ Cardiovasc Imaging 14:1–12CrossRef

Bonaca MP, Olenchock BA, Salem JE, Wiviott SD, Ederhy S, Cohen A, Stewart GC, Choueiri TK, Di Carli M, Allenbach Y, Kumbhani DJ, Heinzerling L, Amiri-Kordestani L, Lyon AR, Thavendiranathan P, Padera R, Lichtman A, Liu PP, Johnson DB, Moslehi J (2019) Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology. Circulation 140:80–91PubMedPubMedCentralCrossRef

Arciniegas Calle MC, Sandhu NP, Xia H, Cha SS, Pellikka PA, Ye Z, Herrmann J, Villarraga HR (2018) Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. BMC Cancer 18

Yoldas T, Yesil S, Karademir S, Sahin G, Arman Orun U, Dogan V, Ozgur S (2019) Evaluation of long-term cardiac side effects of anthracycline chemotherapy by conventional and non-conventional echocardiographic methods in childhood cancer survivors. Cardiol Young 29:904–909PubMedCrossRef

Slieker MG, Fackoury C, Slorach C, Hui W, Friedberg MK, Fan CS, Manlhiot C, Dillenburg R, Kantor P, Mital S, Liu P, Nathan PC, Mertens L (2019) Echocardiographic assessment of cardiac function in pediatric survivors of anthracycline-treated childhood cancer. Circ Cardiovasc Imaging 12:e008869PubMedCrossRef

Pourier MS, Mavinkurve-Groothuis AMC, Dull MM, Weijers G, Loonen J, Bellersen L, de Korte CL, Kapusta L (2020) Myocardial 2D strain during long-term (>5 Years) follow-up of childhood survivors of acute lymphoblastic leukemia treated with anthracyclines. Am J Cardiol 127:163–168PubMedCrossRef

Lambert J, Lamacie M, Thampinathan B, Altaha MA, Esmaeilzadeh M, Nolan M, Fresno CU, Somerset E, Amir E, Marwick TH, Wintersperger BJ, Thavendiranathan P (2020) Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity. Heart 106:817–823PubMedCrossRef

Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, Ganame J, Sebag IA, Agler DA, Badano LP, Banchs J, Cardinale D, Carver J, Cerqueira M, DeCara JM, Edvardsen T, Flamm SD, Force T, Griffin BP, Jerusalem G, Liu JE, Magalhaes A, Marwick T, Sanchez LY, Sicari R, Villarraga HR, Lancellotti P (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 27:911–939PubMedCrossRef

Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, Group ESCSD (2016) 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (ESC). Eur Heart J 37:2768–2801PubMedCrossRef

10.

Nhola LF, Abdelmoneim SS, Villarraga HR, Kohli M, Grothey A, Bordun KA, Cheung M, Best R, Cheung D, Huang R, Barros-Gomes S, Pitz M, Singal PK, Jassal DS, Mulvagh SL (2019) Echocardiographic assessment for the detection of cardiotoxicity due to vascular endothelial growth factor inhibitor therapy in metastatic renal cell and colorectal cancers. J Am Soc Echocardiogr 32:267–276PubMedCrossRef

11.

Cascino GJ, Voss WB, Canaani J, Furiasse N, Rademaker A, Ky B, Luger S, Altman JK, Foran JM, Litzow MR, Tallman MS, Rigolin V, Akhter N (2019) Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia. Echocardiography 36:2033–2040PubMedPubMedCentralCrossRef

12.

Chen J, Wang L, Wu FF, Sun G (2019) Early detection of cardiotoxicity by 3D speckle tracking imaging of area strain in breast cancer patients receiving chemotherapy. Echocardiography 36:1682–1688PubMedCrossRef

13.

Collier P, Phelan D, Klein A (2017) A test in context: myocardial strain measured by speckle-tracking echocardiography. J Am Coll Cardiol 69:1043–1056PubMedCrossRef

14.

Chow EJ, Leger KJ, Bhatt NS, Mulrooney DA, Ross CJ, Aggarwal S, Bansal N, Ehrhardt MJ, Armenian SH, Scott JM, Hong B (2019) Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment. Cardiovasc Res 115:922–934PubMedPubMedCentralCrossRef

15.

Cetin S, Babaoglu K, Basar EZ, Deveci M, Corapcioglu F (2018) Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: assessment by speckle tracking echocardiography. Echocardiography 35:234–240PubMedCrossRef

16.

Akam-Venkata J, Kadiu G, Galas J, Lipshultz SE, Aggarwal S (2019) Left ventricle segmental function in childhood cancer survivors using speckle-tracking echocardiography. Cardiol Young 29:1494–1500PubMedCrossRef

17.

Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, Tian G, Kirkpatrick ID, Singal PK, Krahn M, Grenier D, Jassal DS (2011) The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol 57:2263–2270PubMedCrossRef

18.

Akam-Venkata J, Galas J, Aggarwal S (2019) Cardiovascular evaluation of children with malignancies. Curr Treat Options Cardiovasc Med 21:14PubMedCrossRef

19.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt J-U (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 28:1-39.e14PubMedCrossRef

20.

Galli E, Leclercq C, Fournet M, Hubert A, Bernard A, Smiseth OA, Mabo P, Samset E, Hernandez A, Donal E (2018) Value of myocardial work estimation in the prediction of response to cardiac resynchronization therapy. J Am Soc Echocardiogr 31:220–230PubMedCrossRef

21.

Smiseth OA, Donal E, Penicka M, Sletten OJ (2021) How to measure left ventricular myocardial work by pressure-strain loops. Eur Heart J Cardiovasc Imaging 22:259–261PubMedCrossRef

22.

Yu Kang M, Scherrer-Crosbie M (2019) Echocardiography imaging of modalities. Cardiol Clin. 37:419–427PubMedCrossRef

23.

Anqi Y, Yu Z, Mingjun X, Xiaoli K, Mengmeng L, Fangfang L, Mei Z (2019) Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy. Echocardiography 36:495–502PubMedCrossRef

24.

Thuny F, Huttin O, Ederhy S (2019) Cardio-oncology: clinical and imaging perspectives for optimal cardiodetection and cardioprotection in patients with cancer. Arch Cardiovasc Dis 112:550–558PubMedCrossRef

25.

Yazaki K, Takahashi K, Shigemitsu S, Yamada M, Iso T, Kobayashi M, Akimoto K, Tamaichi H, Fujimura J, Saito M, Nii M, Shimizu T (2018) In-depth insight into the mechanisms of cardiac dysfunction in patients with childhood cancer after anthracycline treatment using layer-specific strain analysis. Circ J 82:715–723PubMedCrossRef

26.

Potter E, Marwick TH (2018) Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc Imaging 11:260–274PubMedCrossRef

27.

Patel NR, Chyu CK, Satou GM, Halnon NJ, Nguyen KL (2018) Left atrial function in children and young adult cancer survivors treated with anthracyclines. Echocardiography 35:1649–1656PubMedCrossRef

28.

Gurdogan M, Ozkan U (2019) A novel predictor of chemotherapeutic cardiotoxicity in patients with non-hodgkin lymphoma. Oncol Res Treat 42:375–381PubMedCrossRef

29.

Lorenzini C, Lamberti C, Aquilina M, Rocca A, Cortesi P, Corsi C (2017) Reliability of left ventricular ejection fraction from three-dimensional echocardiography for cardiotoxicity onset detection in patients with breast cancer. J Am Soc Echocardiogr 30:1103–1110PubMedCrossRef

30.

Sonaglioni A, Albini A, Fossile E, Pessi MA, Nicolosi GL, Lombardo M, Anza C, Ambrosio G (2020) Speckle-tracking echocardiography for cardioncological evaluation in bevacizumab-treated colorectal cancer patients. Cardiovasc Toxicol 20:581–592PubMedCrossRef

31.

Hochstadt A, Arnold J, Rosen R, Sherez C, Sherez J, Mor L, Moshkovits Y, Merdler I, Szekely Y, Arbel Y, Rozenbaum Z, Kapusta L, Topilsky Y, Laufer-Perl M (2021) Longitudinal diastolic strain slope as an early sign for systolic dysfunction among patients with active cancer. Clin Res Cardiol 110:569–578PubMedCrossRef

32.

Filomena D, Versacci P, Cimino S, Mattiucci C, Maestrini V, Cantisani D, Petronilli V, Agati L, Schiavetti A (2020) Echocardiographic long-term follow-up of adult survivors of pediatric cancer treated with dexrazoxane-anthracyclines association. Int J Cardiol 299:271–275PubMedCrossRef

33.

Junzhen Zhan JVdE, Cordrey K, Long R, Danford DA, Hays AG, Barnes BT, Kutty S (2022) Deterioration in myocardial work indices precedes changes in global longitudinal strain following anthracycline chemotherapy. Int J Cardiol 363:171–178PubMedCrossRef

34.

Hubert A, Le Rolle V, Leclercq C, Galli E, Samset E, Casset C, Mabo P, Hernandez A, Donal E (2018) Estimation of myocardial work from pressure-strain loops analysis: an experimental evaluation. Eur Heart J Cardiovasc Imaging 19:1372–1379PubMedCrossRef

35.

Chan J, Edwards NFA, Khandheria BK, Shiino K, Sabapathy S, Anderson B, Chamberlain R, Scalia GM (2019) A new approach to assess myocardial work by non-invasive left ventricular pressure-strain relations in hypertension and dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging 20:31–39PubMedCrossRef

36.

Wang CL, Chan YH, Wu VC, Lee HF, Hsiao FC, Chu PH (2021) Incremental prognostic value of global myocardial work over ejection fraction and global longitudinal strain in patients with heart failure and reduced ejection fraction. Eur Heart J Cardiovasc Imaging 22:348–356PubMedCrossRef

37.

Roemer S, Jaglan A, Santos D, Umland M, Jain R, Tajik AJ, Khandheria BK (2021) The utility of myocardial work in clinical practice. J Am Soc Echocardiogr 34:807–818PubMedCrossRef

38.

Moke DJ, Schubert LE, Sun HY, Printz BF, Dietz AC (2018) Utility of echocardiography as screening for late-onset anthracycline-induced cardiotoxicity in pediatric cancer survivors: observations from the first decade after end of therapy. J Pediatr Hematol Oncol 40:e283-283PubMedCrossRef

39.

Liu J, Banchs J, Mousavi N, Plana JC, Scherrer-Crosbie M, Thavendiranathan P, Barac A (2018) Contemporary role of echocardiography for clinical decision making in patients during and after cancer therapy. JACC Cardiovasc Imaging 11:1122–1131PubMedCrossRef

40.

Plana JC, Thavendiranathan P, Bucciarelli-Ducci C, Lancellotti P (2018) Multi-modality imaging in the assessment of cardiovascular toxicity in the cancer patient. JACC Cardiovasc Imaging 11:1173–1186PubMedCrossRef

41.

Manganaro R, Marchetta S, Dulgheru R, Sugimoto T, Tsugu T, Ilardi F, Cicenia M, Ancion A, Postolache A, Martinez C, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, van de Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Rosca M, Calin A, Moonen M, Magne J, Cosyns B, Galli E, Donal E, Carerj S, Zito C, Santoro C, Galderisi M, Badano LP, Lang RM, Lancellotti P (2020) Correlation between non-invasive myocardial work indices and main parameters of systolic and diastolic function: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 21:533–541PubMedCrossRef

42.

Boyd A, Stoodley P, Richards D, Hui R, Harnett P, Vo K, Marwick T, Thomas L (2017) Anthracyclines induce early changes in left ventricular systolic and diastolic function: a single centre study. PLoS ONE 12:e0175544PubMedPubMedCentralCrossRef

43.

Florescu M, Magda LS, Enescu OA, Jinga D, Vinereanu D (2014) Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer. J Am Soc Echocardiogr 27:83–92PubMedCrossRef

44.

Hu HM, Zhang XL, Zhang WL, Huang DS, Du ZD (2018) Detection of subclinical anthracyclines’ cardiotoxicity in children with solid tumor. Chin Med J (Engl) 131:1450–1456PubMedCrossRef

45.

Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH (2014) Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 63:2751–2768PubMedCrossRef

46.

Luo R, Cui H, Huang D, Li G (2017) Early assessment of the left ventricular function by epirubicin-induced cardiotoxicity in postoperative breast cancer patients. Echocardiography 34:1601–1609PubMedCrossRef

Title: Evaluation the Effect of Anthracyclines on Cardiac Function in Children Lymphoma Survivors by Left Ventricular Myocardial Work
Authors: Yuqiong An
Li Xue
Liyuan Xu
Chao Zhang
Yijie Yang
Yong Liu
Ning Ma
Publication date: 25-04-2024
Publisher: Springer US
Keywords: Anthracycline
Lymphoma
Cytostatic Therapy
Echocardiography
Echocardiography
Published in: Pediatric Cardiology
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-024-03480-2

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Evaluation the Effect of Anthracyclines on Cardiac Function in Children Lymphoma Survivors by Left Ventricular Myocardial Work

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page